Bicocca Open Archive

Logo unimib boa
LOCATELLI, VITTORIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.887
AS - Asia 5.507
EU - Europa 5.163
SA - Sud America 730
AF - Africa 75
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 10
Totale 23.386
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.635
SG - Singapore 1.659
CN - Cina 1.424
IT - Italia 1.041
VN - Vietnam 1.030
HK - Hong Kong 840
DE - Germania 807
RU - Federazione Russa 788
BR - Brasile 598
SE - Svezia 526
IE - Irlanda 515
UA - Ucraina 491
GB - Regno Unito 327
CA - Canada 203
FI - Finlandia 163
AT - Austria 118
IN - India 113
FR - Francia 102
KR - Corea 95
ID - Indonesia 78
TR - Turchia 66
DK - Danimarca 54
AR - Argentina 52
NL - Olanda 49
BE - Belgio 42
PL - Polonia 41
BD - Bangladesh 40
ZA - Sudafrica 39
JP - Giappone 33
MX - Messico 32
EC - Ecuador 25
IQ - Iraq 25
BG - Bulgaria 22
CH - Svizzera 22
CO - Colombia 16
ES - Italia 14
SA - Arabia Saudita 12
EU - Europa 11
PY - Paraguay 11
PK - Pakistan 10
CZ - Repubblica Ceca 9
IR - Iran 9
CL - Cile 8
TW - Taiwan 8
AU - Australia 7
EE - Estonia 7
EG - Egitto 7
IL - Israele 7
KE - Kenya 7
LB - Libano 7
MY - Malesia 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
MA - Marocco 6
NP - Nepal 6
PE - Perù 6
RO - Romania 6
UY - Uruguay 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 4
GT - Guatemala 4
KZ - Kazakistan 4
PT - Portogallo 4
SC - Seychelles 4
AL - Albania 3
DZ - Algeria 3
HN - Honduras 3
JM - Giamaica 3
KG - Kirghizistan 3
NZ - Nuova Zelanda 3
SN - Senegal 3
TN - Tunisia 3
BH - Bahrain 2
BO - Bolivia 2
CR - Costa Rica 2
HU - Ungheria 2
JO - Giordania 2
LT - Lituania 2
PH - Filippine 2
PS - Palestinian Territory 2
RS - Serbia 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
ET - Etiopia 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LI - Liechtenstein 1
MD - Moldavia 1
ML - Mali 1
MU - Mauritius 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
SI - Slovenia 1
Totale 23.384
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.605
Woodbridge 1.090
Singapore 1.036
Fairfield 979
Ashburn 923
Hong Kong 839
Houston 788
Chandler 736
Wilmington 720
Frankfurt am Main 546
Jacksonville 504
Dublin 494
Seattle 444
Dearborn 323
Ho Chi Minh City 313
Cambridge 310
Beijing 295
Milan 294
Hanoi 250
New York 247
Princeton 211
Santa Clara 187
Hefei 178
Los Angeles 147
Dallas 140
Nanjing 136
Vienna 104
Chicago 93
Lawrence 87
Seoul 87
Altamura 86
Lachine 82
Shanghai 82
Moscow 79
Buffalo 69
Jakarta 69
Boardman 58
São Paulo 57
Helsinki 54
Council Bluffs 51
Guangzhou 51
London 48
Detroit 47
Brussels 41
Nanchang 41
Rome 41
Falls Church 40
San Diego 40
Da Nang 37
The Dalles 37
Haiphong 36
Munich 36
Hebei 32
Andover 29
Nuremberg 28
Toronto 28
Changsha 27
Kent 27
Mountain View 26
Shenyang 26
Tianjin 25
Ha Long 24
Huizen 24
Tokyo 24
Biên Hòa 23
Elora 23
Fremont 23
Rio de Janeiro 23
Salt Lake City 21
Warsaw 21
Grafing 20
Jiaxing 20
Philadelphia 20
Ottawa 19
Pune 19
Turku 19
Renton 18
Can Tho 17
Hangzhou 17
Jinan 17
Kunming 17
Monza 16
Plovdiv 16
Poplar 16
Quận Bình Thạnh 16
San Francisco 16
Brooklyn 15
Bologna 14
Hải Dương 14
Redondo Beach 14
Thái Nguyên 14
Turin 14
Denver 13
Dhaka 13
Norwalk 13
Stockholm 13
Atlanta 12
Ningbo 12
Orem 12
Phoenix 12
Totale 16.210
Salva come PNG Salva come JPEG
Nome #
Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study 448
Anti-inflammatory effects of palmitoylethanolamide in activated microglial cells 414
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 396
Growth hormone secretagogues and the regulation of calcium signaling in muscle 390
TLQP-21, A VGF-derived peptide endowed of endocrine and extraendocrine properties: Focus on in vitro calcium signaling 347
Intra-Articular Cytokine Levels in Adolescent Patients after Anterior Cruciate Ligament Tear 346
Effects of ACL Reconstructive Surgery on Temporal Variations of Cytokine Levels in Synovial Fluid 323
Biophysical characterization of a binding site for TLQP-21, a naturally occurring peptide which induces resistance to obesity 320
Role of interleukin-10 in the synovial fluid of the anterior cruciate ligament injured knee 306
STIM Proteins and Orai Ca2+ Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 Macrophages 299
Hexarelin modulation of mapk and pi3k/akt pathways in neuro-2a cells inhibits hydrogen peroxide-induced apoptotic toxicity 297
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues 295
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 273
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis 265
Characterization of synovial fluid cytokine profiles in chronic meniscal tear of the knee 264
Development of Growth Hormone Secretagogues as new therapeutical tools for Amyotrophic Lateral Sclerosis 263
Acute and late changes in intraarticular cytokine levels following anterior cruciate ligament injury 257
Ontogeny and tissue-specific regulation of ghrelin mRNA expression suggest that ghrelin is primarily involved in the control of extraendocrine functions in the rat 256
Neurotrophic and neuroregenerative effects of GH/IGF1 251
Feeding behavior during long-term hexarelin administration in young and old rats 250
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 248
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 242
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein 241
Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21 241
Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites 240
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 240
Ghrelin plays a minor role in the physiological control of cardiac function in the rat 239
Ghrelin in gastroenteric pathophysiology 237
TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity 230
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury 229
Ghrelin control of GH secretion and feeding behaviour: The role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands 227
Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice 226
Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat 224
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 223
Characterisation of gastric ghrelin cells in man and other mammals: studies in adult and fetal tissues 220
Central ghrelin gastroprotection involves nitric oxide/prostaglandin cross-talk 220
Somatotropic dysregulation in old mammals 218
Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears 217
Mechanism of action of Hexarelin. I. Growth hormone-releasing activity in the rat 217
Central nervous system-acting drugs influencing hypothalamic-pituitary-adrenal axis function 214
Ghrelin expression and actions: A novel peptide for an old cell type of the diffuse endocrine system 213
Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa 213
Desacyl-ghrelin and Synthetic GH-secretagogues Modulate the Production of Inflammatory Cytokines in Mouse Microglia Cells Stimulated by beta-Amyloid Fibrils 213
Beneficial effects of desacyl-ghrelin, hexarelin and EP-80317 in models of status epilepticus 209
Evidence for a central inhibitory role of growth hormone secretagogues and ghrelin on gastric acid secretion in conscious rats 209
Studio longitudinale sul benessere e le attitudini degli Studenti di Medicina e Chirurgia. Primi risultati della fase 1 - Le caratteristiche degli studenti selezionati. 209
Effects of hexarelin against acid-independent and acid-dependent ulcerogens in the rat 208
Utilizzo dei growth hormone secretagogues per bloccare o inibire l'attività del sistema renina-angiotensina 208
Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release 208
Age-dependent modulation by galanin of growth hormone release from rat pituitary cells in culture 207
Intracerebroventricular acute and chronic administration of obestatin minimally affect food intake but not weight gain in the rat. 204
Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients 201
Penile erection induced by EP 80661 and other hexarelin peptide analogues: Involvement of paraventricular nitric oxide 200
Growth hormone-releasing hexapeptide is a potent stimulator of growth hormone gene expression and release in the growth hormone-releasing hormone-deprived infant rat 200
Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin 199
EP 60761 and EP 50885, two hexarelin analogues, induce penile erection in rats 197
Involvement of the somatostatin and cholinergic systems in the mechanism of growth hormone autofeedback regulation in the rat 193
Long-term changes of somatotrophic function induced by deprivation of growth hormone-releasing hormone during the fetal life of the rat 193
Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo 193
Functional and Structural Characterization of a Binding Site for TLQP-21, a VGF-Derived Peptide 191
Growth hormone and hexarelin prevent endothelial vasodilator dysfunction in aortic rings of the hypophysectomized rat 190
Selected Growth Hormone Secretagogues (GHS) as promising therapeutical approach for Amyotrophic Lateral Sclerosis: a proof-of-concept study 189
Ghrelin inhibits inflammatory pain in rats: Involvement of the opioid system 189
New trisubstituted 1,2,4-triazole derivatives as potent ghrelin receptor antagonists. 3. Synthesis and pharmacological in vitro and in vivo evaluations 189
Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels: I. A study on ad libitum fed and starved adult male rats 189
Growth hormone-inhibiting activity of cortistatin in the rat 188
GH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats 188
La valutazione delle attività di tirocinio pratico da parte dei tutori 188
Growth hormone secretagogues: focus on the growth hormone-releasing peptides 184
IGF-I stimulates proliferation of spontaneously immortalized human keratinocytes (HACAT) by autocrine/paracrine mechanisms 183
Somatotropic dysfunction in growth hormone-releasing hormone-deprived neonatal rats: effect of growth hormone replacement therapy 183
Moexipril and quinapril inhibition of tissue angiotensin-converting enzyme activity in the rat: Evidence for direct effects in heart, lung and kidney and stimulation of prostacyclin generation 182
Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis 180
Pyruvate and satiety: can we fool the brain? 179
Low dose of insulin for assessment of growth hormone and cortisol release in short children 178
Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications 177
Protective but not anticonvulsant effects of ghrelin and JMV-1843 in the pilocarpine model of Status epilepticus 177
The somatostatin subtype-2 receptor antagonist, BIM-23627, improves the catabolic effects induced by long-term glucocorticoid treatment in the rat. 176
Growth hormone-independent cardioprotective effects of hexarelin in the rat 174
Hexarelin stimulation of growth hormone release and mrna levels in an infant and adult rat model of impaired ghrh function 173
Age-related modulatory activity by a cholinergic agonist on the growth hormone response to GH-releasing hormone in the rat 172
Chronic intracerebroventricular TLQP-21 delivery does not modulate the GH/IGF-1-axis and muscle strength in mice 170
Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. Synthesis and pharmacological in vitro and in vivo evaluations 169
PHARMACOLOGICAL CHARACTERIZATION OF A BINDING SITE FOR TLQP-21, A VGF-DERIVED PEPTIDE 168
Testosterone a key factor in gender related metabolic syndrome 168
Ghrelin expression in gut endocrine growths 167
Neural stem cells release soluble factors that modulate inflammatory cytokines expression in microglia 167
EP 60761- and EP 50885-induced penile erection: structure-activity studies and comparison with apomorphine, oxytocin and N-methyl-D-aspartic acid 166
Inibition of H2O2-induced neurotoxicity in mouse neuroblastoma Neuro2A cells by microvescicles released from hexarelin-stimulated microglial cells 166
Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels: II. A study in the infant rat 164
La somatopausa: nuove prospettive terapeutiche 162
Differential orexigenic effects of hexarelin and its analogs in the rat hypothalamus: indication for multiple growth hormone secretagogue receptor subtypes 158
Key Learning Outcomes for Clinical Pharmacology and Therapeutics Education in Europe: A Modified Delphi Study 157
Antioxidant and neuroprotective effects of Hexarelin in Neuro-2A cells 157
Synthesis and pharmacological in vitro and in vivo evaluations of novel triazole derivatives as ligands of the ghrelin receptor. 1 154
L’accesso a Medicina. Best evidence-based practice, requisito indispensabile per una ipotesi di “Processo di Selezione” centrato sulla realtà formativa italiana e di caratura internazionale 151
Chronic i.c.v infusion either of a melanocortin agonist or of an antagonist at low doses profoundly modifies energy balance without any other behavioral effects, in rats 148
New active series of growth hormone secretagogues 148
Evidence for a role of the GHS-R1a receptors in ghrelin inhibition of gastric acid secretion in the rat 147
EP1572: A novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man 145
Totale 21.781
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.640
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.640
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.064 0 0 0 0 0 160 173 150 153 214 83 131
2021/20221.199 63 109 149 57 52 113 57 51 83 109 118 238
2022/20232.766 284 742 282 282 239 421 30 143 181 17 90 55
2023/20241.584 63 73 78 83 225 395 313 44 105 18 28 159
2024/20253.743 215 352 234 239 349 161 271 223 257 519 281 642
2025/20265.037 1.467 815 695 968 984 108 0 0 0 0 0 0
Totale 23.819